Weaker Buy Today CBPO ranks #1797 as BUY CANDIDATE #1797 Stronger Buy

China Biologic Products stock forecast

CBPO stock forecast

Wednesday June 19, 2019 Change 1.40% Price $94.39
Chart period: 2019-03-20 - 2019-06-19
VOLUME
Sell
TREND
Sell
MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Will CBPO stock price go up or down on Thu, 20 Jun 2019?

Predict

China Biologic Products Forecast and Stock Analysis

Technical CBPO stock analysis for Wednesday June 19, 2019.

Buy candidate since 2019-06-19


China Biologic Products gained 1.40% in the last trading day ( Wednesday, 19th Jun 2019 ), rising from $93.09 to $94.39 During day the stock fluctuated 3.12% from a day low at $92.35 to a day high of $95.23. The price has risen in 7 of the last 10 days and is up by 5.17% over the past 2 weeks. Volume fell in the last day by -14 393 shares, and in total, 104 338 shares bought and sold for approximately $9.85 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the CBPO stock price was $95.23 and low was $88.00.
  • 90 day high was $101.23 and low was $86.71.
  • 52 week high for the China Biologic Products - $107.44 and low - $60.08.

Trend

China Biologic Products lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.24% during the next 3 months and, with 90% probability hold a price between $86.43 and $97.23 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. China Biologic Products holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $92.24 and $92.29. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday June 07, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 74 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

China Biologic Products finds support from accumulated volume at $92.83.

Support: $92.83 Price: $94.39 Resistance: $96.57

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.88 (3.12%) between high and low. For the last week, the stock has had a daily average volatility of 2.26%.

Our recommended stoploss: $90.96 (-3.63%) (This stock has low daily movements and this gives low risk. The RSI14 is 74 and this increases the risk substantially. There is a buy signal from pivot bottom found 8 days ago.)

2.26 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.

Buy Candidate Upgraded
Weaker Buy Today CBPO ranks #1797 as BUY CANDIDATE #1797 Stronger Buy

Will CBPO stock price go up or down on Thu, 20 Jun 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank